about
Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settingsIncome and child mortality in developing countries: a systematic review and meta-analysisRespiratory risks from household air pollution in low and middle income countriesThe quality and diagnostic value of open narratives in verbal autopsy: a mixed-methods analysis of partnered interviews from MalawiCost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian childrenUse of health services by remote dwelling Aboriginal infants in tropical northern Australia: a retrospective cohort studyHuman melioidosis, Malawi, 2011.Adherence to management guidelines for growth faltering and anaemia in remote dwelling Australian Aboriginal infants and barriers to health service deliveryEffectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.Determination of a Viral Load Threshold To Distinguish Symptomatic versus Asymptomatic Rotavirus Infection in a High-Disease-Burden African Population.Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.Minimum incidence of adult invasive pneumococcal disease in Blantyre, Malawi an urban african setting: a hospital based prospective cohort studyHigh multiple carriage and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children.Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study.Evidence behind the WHO guidelines: Hospital Care for Children: efficacy and safety of artemisinin derivatives in children with malaria.Combination conjugate vaccines.Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control AnalysesMeasuring indirect effects of rotavirus vaccine in low income countriesRespiratory Virus-Associated Severe Acute Respiratory Illness and Viral Clustering in Malawian Children in a Setting With a High Prevalence of HIV Infection, Malaria, and Malnutrition.Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012.Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi.Vitamin D insufficiency among hospitalised children in the Northern Territory.The economic impact of childhood acute gastroenteritis on Malawian families and the healthcare system.Use of maternal health services by remote dwelling Aboriginal women in northern Australia and their disease burden.Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study.Lumbar microdiscectomy and post-operative activity restrictions: a protocol for a single blinded randomised controlled trial.Preliminary report from the World Health Organisation Chest Radiography in Epidemiological Studies projectOctreotide in children with hypoglycaemia due to sulfonylurea ingestion.Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-like backbone post rotavirus vaccine introduction in Malawi.Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titresIn utero herpes simplex encephalitis.The effect of illicit financial flows on time to reach the fourth Millennium Development Goal in Sub-Saharan Africa: a quantitative analysis.Use of evidence in WHO recommendationsEvaluating strategies to improve rotavirus vaccine impact during the second year of life in MalawiHigh residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
P50
Q26800157-7163438D-F8AA-41FF-9301-5429E0DEC007Q27001171-43B6F363-46A5-4881-94C3-ED72A25FE7C8Q28391847-8CE3C0A2-4178-4D68-A751-10D87329B38BQ28601583-AB5E7662-523B-428E-9853-BF2744AAAFCBQ31072142-CF30295E-8182-47C9-951E-3F5D8D2CD107Q33745704-A3E31D9A-A578-4D90-A7FB-080AC7FB8010Q34176458-EF3CF4D2-853A-401F-BC69-F383048DD2FEQ34348592-B0FE4CAF-1F25-4941-9899-33BE1380A570Q34790365-C599E94F-3A36-4833-AC4E-101BC6D3F726Q35217987-C9A8EB79-1750-4126-A55C-41BC6560326FQ35607488-6639CE20-E22C-4AB9-A6CB-626D114DD2ADQ35635402-588DD495-EFB1-4D64-BAC8-ADA3CCA7BD5DQ35651036-0E4854D9-A544-4B2C-AD8E-A6C81872B018Q35667974-47F50508-E4AE-4985-9C3B-0631EE4BB71AQ36010573-97F55F7A-2D9E-4384-99D7-08F13E34CE0BQ36239337-0B8BB712-661F-408E-8C46-03EE39ACA376Q36425223-A4A9EDA7-72E5-4790-9558-D96F6BE2AD2FQ36446881-109FE930-DF2C-4690-9600-CC33E766EE1AQ36781547-01AB2974-553E-4528-8985-3841054C8269Q37306509-16F529D1-C8F2-4C0C-8A35-6F9A2BC328CFQ37685848-160E19B7-7234-4ED8-9D7D-EEAE75B33BA3Q37726056-FC813AC6-F582-4EE1-AFE8-51740541C55FQ38599577-14144139-F0CB-43D8-97C2-AF78A10B92B1Q38657132-9828B505-F648-46AD-B946-7E050CB158B0Q38909377-FC85FD03-07BB-416E-A9BB-19FA1685133CQ39063800-801850E2-7C16-41A0-B018-321254563E69Q39229900-BBEF8DFC-2C0C-4544-AD7C-6F27E19FB4A1Q39284005-1892F3D8-446F-4215-A8CD-E38E7C3D87BAQ40126075-C47465BA-884D-4EF3-B425-9ACA371A5156Q42362270-5DD2601F-73B5-4A31-A1FB-22461367B532Q46598369-6FF54C70-1DD6-426C-BD30-C74203B96AEDQ46851254-6CD70889-D13C-45C7-AE1A-F51864E00A71Q47005046-B8B1289D-680A-4B12-9771-13776E2612C6Q48150602-22B2649A-5056-4963-B37F-2C640A971E66Q54445299-E1867F86-040F-4331-9498-408A01136DADQ59383928-CECBBAE3-914E-4BAA-BC6B-4439473E2BB9Q92623430-2D10595F-1B1A-4075-AC8E-81A5CD166BF2Q94591449-C0065640-AADE-4850-B073-BF90BD374482
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Naor Bar-Zeev
@ast
Naor Bar-Zeev
@en
Naor Bar-Zeev
@es
Naor Bar-Zeev
@nl
type
label
Naor Bar-Zeev
@ast
Naor Bar-Zeev
@en
Naor Bar-Zeev
@es
Naor Bar-Zeev
@nl
prefLabel
Naor Bar-Zeev
@ast
Naor Bar-Zeev
@en
Naor Bar-Zeev
@es
Naor Bar-Zeev
@nl
P106
P1153
8372787000
P21
P31
P496
0000-0003-0570-4624